# K133924: Endoluminal Occlusion System (Eos)

- Pathway: 510(k) (Abbreviated)
- Applicant: Artventive Medical Group, Inc.
- Decided: Dec 3, 2014 after 345 days
- Product code: KRD (Device, Vascular, For Promoting Embolization)
- Device class: 2
- Regulation: 21 CFR 870.3300
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 14 generations back to K951256 (1995). 84 ancestors in all.
2 later devices descend from it; 1 cites it directly.
0 of 87 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K071125: Amplatzer Vascular Plug II Models: AVP2-004, AVP2-006, AVP2-008, AVP2-010, AVP2-012, AVP2-014, AVP2-016, Aga Medical Corp. (2007) Summary page 4.
- K113658: Amplatzer Vascular Plug 4, Aga Medical Corp. (2012) Summary page 4.
- K123803: Reverse Medical Micro Vascular Plug (MVP) System, Reverse Medical Corporation (2013) Summary page 4.

## Most influential descendants
- K150402: Endoluminal Occlusion System-EOS (2015), 1 descendant of its own
- K212057: Endoluminal Occlusion System, EOS-X, Endoluminal Occlusion System, EOS (2022), 0 descendants of its own

## Indications for use
The ArtVentive Medical Group Endoluminal Occlusion System (AVMG EOS) is indicated for the percutaneous occlusion of the peripheral arterial and venous vasculature.

Source page: https://510kreport.com/device/K133924
Methodology: https://510kreport.com/methodology